The θ-defensin retrocyclin 101 inhibits TLR4- and TLR2-dependent signaling and protects mice against influenza infection.

Treatment with RC‐101, starting 2 d postinfection, was shown to lessen the severity of PR8‐associated disease, resulting in a highly significant increase in survival ( Fig. 7 ).

also in 132,142 other papers